In the interim, NICE-approved options for weight management in adults with obesity include: Orlistat (available on NHS prescription) Semaglutide 2.4 mg (Wegovy) , recommended by NICE in 2023 for use in specific patient groups (NICE technology appraisal TA875) Tirzepatide (Mounjaro) , which received NICE approval in 2024 for obesity management (NICE technology appraisal TA1026) [18] Patients seeking advice about weight management or blood pressure control should be directed to their GP in the first instance, who can assess eligibility for currently approved treatments and refer to specialist services where appropriate
Nausea and Vomiting: What to Expect Regurgitating food or liquids can be a frustrating and uncomfortable experience
Taking GLP-1 medication changes your appetite, digestion, and nutritional needs
You have significant nausea, vomiting, constipation, poor intake, or dehydration symptoms
However, L-carnitine is a larger molecule and does not pass easily through the skin, and there is limited scientific information showing how well it is absorbed from patches 14